Changing landscape of immunosuppression in ANCA-associated vasculitis
Changing landscape of immunosuppression in ANCA-associated vasculitis
About this item
Full title
Author / Creator
Publisher
England: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Unlike methotrexate, MMF can be used in patients with moderate or severe renal disease. [...]remission induction treatment with MMF was similar in efficacy to pulsed cyclophosphamide in patients with lupus nephritis.2 It seems that MPO-ANCA associated renal vasculitis may be a primary indication for administration of MMF. Only patients with newly d...
Alternative Titles
Full title
Changing landscape of immunosuppression in ANCA-associated vasculitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2229089331
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2229089331
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2019-215123
